Cargando…
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
BACKGROUND: Recent data provide significant evidence to support the hypothesis that there are sub-populations of cells within solid tumors that have an increased tumor initiating potential relative to the total tumor population. CD133, a cell surface marker expressed on primitive cells of neural, he...
Autores principales: | Friel, Anne M, Zhang, Ling, Curley, Michael D, Therrien, Vanessa A, Sergent, Petra A, Belden, Sarah E, Borger, Darrell R, Mohapatra, Gayatry, Zukerberg, Lawrence R, Foster, Rosemary, Rueda, Bo R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027593/ https://www.ncbi.nlm.nih.gov/pubmed/21122138 http://dx.doi.org/10.1186/1477-7827-8-147 |
Ejemplares similares
-
Prognostic impact of CD133 expression in Endometrial Cancer Patients
por: Mancebo, G., et al.
Publicado: (2017) -
Expression of CD133 in endometrial cancer cells and its implications
por: Ding, Dah-Ching, et al.
Publicado: (2017) -
Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018) -
Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016) -
Human osteosarcoma CD49f(−)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity
por: Ying, Meidan, et al.
Publicado: (2012)